Gennex Laboratories Share Price

    11.96
    -0.20 (-1.64%)
    GENNEX • 26 Aug, 2025 | 10:28 AM
    Buy

    1Y Annualised Return

    -39.04%

    3Y Annualised Return

    22.86%

    5Y Annualised Return

    19.31%

    10Y Annualised Return

    15.30%

    The current prices are delayed, login or Open Demat Account for live prices.

    Gennex Laboratories Stock Performance

    1W Return-3.39
    1Y Return-39.60
    Today's Low11.85
    Prev. Close12.16
    Mkt Cap (Cr.)276.58
    1M Return-8.00
    3Y Return83.44
    52-Week High29
    Open12.16
    PE Ratio19.61
    6M Return-11.21
    Today's High12.19
    52-Week Low11.15
    Face Value1

    Gennex Laboratories Company background

    Founded in: 1990
    Managing director: Arihant Baid
    Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985. The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007.The Company is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates. It is engaged in manufacturing and marketing of bulk drugs and intermediates. Gennex is among the leading Vertically Integrated pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal. The company thrives on the strength of its exports to various countries viz. Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and Others. The Companys factory is situated at Andhra Pradesh, India. The company has a professionally managed team at every stage of its operations.During the year 20052006, the company implemented GMP (Good Manufacturing Practices). In 200607, it installed Separate Air Handling System in final drug isolation area and also in drying and packing area. Also, it implemented the CGMP in manufacturing area as per ICH WHO Guidelines. In 20072008, it diversified into the business of Biotech product. The Company acquired 51% shareholding in Deccan Remedies Limited and thus became the subsidiary of the Company in 2023.

    Gennex Laboratories Financial Highlights


    For the full year FY2025–2026, revenue reached ₹148.33 crore and profit touched at ₹18.12 crore.

    As of 26 Aug, 2025, Gennex Laboratories share price is ₹12. The stock opened at ₹12.2 and had closed at ₹12.2 the previous day. During today’s trading session, Gennex Laboratories share price moved between ₹11.85 and ₹12.19, with an average price for the day of ₹12.02. Over the last 52 weeks, the stock has recorded a low of ₹11.15 and a high of ₹29.00. In terms of performance, Gennex Laboratories share price has declined by 11.2% over the past six months and has declined by 39.04% over the last year.
    Read More
    Gennex Laboratories SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹53,76,599 (-17.28%)
    Daily SIP of 25,000 would have become 53,76,599 in 1 year with a gain of -11,23,400 (-17.28%)
    View details of Market Depth

    Gennex Laboratories Fundamental

    Market Cap (in crs)

    276.58

    Face Value

    1

    Turnover (in lacs)

    9.22

    Key Metrics

    Qtr Change %
    58.76% Fall from 52W High
    -8.5
    Dividend yield 1yr %
    0

    Gennex Laboratories Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Gennex Laboratories Quarterly Revenue
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    34.18 Cr
    40.33 Cr
    40.01 Cr
    31.55 Cr
    28.32 Cr
    Gennex Laboratories Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    148.33 Cr
    91.62 Cr
    69.56 Cr
    62.6 Cr
    60.17 Cr
    56.57 Cr
    Gennex Laboratories Quarterly Net Profit/Loss
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    5.02 Cr
    3.07 Cr
    5.07 Cr
    5.37 Cr
    4.66 Cr
    Gennex Laboratories Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    18.12 Cr
    13.18 Cr
    4.92 Cr
    3.92 Cr
    4.04 Cr
    1.86 Cr

    Gennex Laboratories Shareholding Pattern

    Promoter
    19.8%
    Public
    80.2%
    Promoter
    18.4%
    Public
    81.6%
    Promoter
    18.4%
    Public
    81.6%
    Promoter
    18.4%
    Public
    81.6%
    Promoter
    18.4%
    Public
    81.6%
    Promoter
    18.4%
    Public
    81.6%

    Gennex Laboratories Technical Analysis

    Moving Averages Analysis
    11.96
    Current Price
    Bullish Moving Averages
    0
    Bearish Moving Averages
    16
    5Day EMA
    12.10
    10Day EMA
    12.20
    12Day EMA
    12.20
    20Day EMA
    12.40
    26Day EMA
    12.50
    50Day EMA
    12.70
    100Day EMA
    13.20
    200Day EMA
    14.10
    5Day SMA
    12.10
    10Day SMA
    12.10
    20Day SMA
    12.40
    30Day SMA
    12.80
    50Day SMA
    12.80
    100Day SMA
    13.00
    150Day SMA
    13.20
    200Day SMA
    14.50
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    132064 Rs
    181792 Rs
    Week Rs
    387924 Rs
    457504 Rs
    Month Rs
    332552 Rs
    429755 Rs
    12.16
    Pivot
    Resistance
    First Resistance
    12.27
    Second Resistance
    12.39
    Third Resistance
    12.50
    Support
    First Support
    12.04
    Second support
    11.93
    Third Support
    11.81
    Relative Strength Index
    43.77
    Money Flow Index
    37.03
    MACD
    -0.26
    MACD Signal
    -0.25
    Average True Range
    0.59
    Average Directional Index
    35.26
    Rate of Change (21)
    -9.39
    Rate of Change (125)
    -12.46

    Gennex Laboratories Latest News

    18 AUG 2025 | Monday

    Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    14 AUG 2025 | Thursday

    Gennex Laboratories Ltd - 531739 - Unaudited Financial Results For The Quarter Ended June 30, 2025

    14 AUG 2025 | Thursday

    Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Outcome Of The Board Meeting Of Gennex Laboratories Limited Held On August 14, 2025 For Unaudited Financial Results Of First Quarter Ended June 30, 2025

    View More

    Gennex Laboratories Share Price FAQs

    You can easily buy Gennex Laboratories shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Gennex Laboratories share price is ₹29 and ₹11.15 as of 26/8/2025.

    Please be aware that Gennex Laboratories stock prices are subject to continuous fluctuations due to various factors.

    Open Demat Account
    +91 -

    Popular Stocks
    56.97
    -0.46 (-0.80%)
    122.65
    -1.71 (-1.38%)
    681.70
    -5.10 (-0.74%)
    2,277.30
    -25.60 (-1.11%)
    146.35
    -1.35 (-0.91%)
    316.15
    -5.50 (-1.71%)
    157.63
    -2.00 (-1.25%)
    318.40
    -0.85 (-0.27%)
    367.85
    -4.20 (-1.13%)
    380.95
    -2.30 (-0.60%)
    Top Gainers
    6,089.00
    +98.50 (+1.64%)
    1,168.70
    +15.70 (+1.36%)
    5,126.60
    +62.80 (+1.24%)
    2,653.70
    +22.10 (+0.84%)
    8,780.00
    +29.50 (+0.34%)
    Top Losers
    1,614.40
    -42.30 (-2.55%)
    606.60
    -14.25 (-2.30%)
    1,262.10
    -21.80 (-1.70%)
    374.50
    -5.50 (-1.45%)
    5,352.00
    -71.00 (-1.31%)
    Open Demat Account
    +91 -